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Biologics remain the fastest growing class of pharmaceutics, with global market growth projected to exceed 400 
billion dollars by 2025 [1].  With this growth comes a need to manufacture diverse biological molecules to treat 
many serious diseases more cost effectively, and to deliver these medicines to the market quickly.  Over the 
past 30 years, advances in life sciences and process engineering have directly contributed to advances in 
biologics manufacturing resulting in efficient processes with unprecedented protein titers.  Nonetheless, 
common challenges still occur for many bioprocesses as they advance from early development through the 
process life cycle.  This presentation discusses how omics technologies in conjunction with traditional 
monitoring techniques can be used to understand and improve cell culture processes [2].  Here we present 
three case studies where Omics technologies were successfully applied to common bioprocessing challenges, 
including scale-up/down, product quality attribute control, and raw material variability.  First, we discuss a legacy 
process which does not scale effectively between lab and manufacturing scales.  In this case, metabolomics 
and proteomics approaches were used to identify a difference in oxidative stress levels at different scales, 
resulting in reduced viability, viable cell density and titer [3].  This learning was then applied to the next 
generation process to successfully develop an optimized scale down model representative of manufacturing 
scale [4].  Next, we show how Omics technologies can be used to increase both understanding and control of 
product quality attributes.  We provide examples where metabolomics and transcriptomics were applied to 
improve cellular and process understanding around protein sialylation, a desirable glycosylation attribute [4], as 
well as α-Gal, an undesirable glycosylation attribute.  In our third case study, we present a metabolomics 
approach to monitor raw material variability in a legacy process.  Manufacturing lots for chemically defined and 
complex media components were analyzed using NMR and LC/MS, and age and storage related degradation 
metabolites were identified.  The impact on process performance was confirmed through spiking studies.  
Finally, we propose strategies for incorporating Omics technologies into bioprocess development and 
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